Skip to main content
Livermore
Livermore
ZHEN

J. Goldman & Co LP

SEC CIK
0001412741
Latest filing
Aug 14, 2026

TARS holding history

Tarsus Pharmaceuticals, Inc. in every 13F filed by J. Goldman & Co LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TARS overviewAll 13F holders of TARSFull Q2 2026 holdings

Shares (Q2 2026)
26,800
Value
$1.69M
% of portfolio
0.1%
Quarters held
20
Since Q2 2021
Holdings of TARS by J. Goldman & Co LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,800$1.69M0.1%+12,259+84.3%AddedHolders
Q1 202614,541$1.02M<0.1%+11,842+438.8%AddedHolders
Q4 20252,699$221.0K<0.1%−41,601−93.9%ReducedHolders
Q3 202544,300$2.63M0.1%−320,257−87.8%ReducedHolders
Q2 2025364,557$14.8M0.5%+224,269+159.9%AddedHolders
Q1 2025140,288$7.21M0.3%+10,093+7.8%AddedHolders
Q4 2024130,195$7.21M0.3%−427,305−76.6%ReducedHolders
Q3 2024557,500$18.3M0.8%+170,339+44.0%AddedHolders
Q2 2024387,161$10.5M0.4%+223,814+137.0%AddedHolders
Q1 2024163,347$5.94M0.3%+91,003+125.8%AddedHolders
Q4 202372,344$1.46M0.1%−53,565−42.5%ReducedHolders
Q3 2023125,909$2.24M0.1%+69,937+124.9%AddedHolders
Q2 202355,972$1.01M0.1%+14,399+34.6%AddedHolders
Q1 202341,573$522.6K<0.1%00.0%UnchangedHolders
Q4 202241,573$609.5K<0.1%00.0%UnchangedHolders
Q3 202241,573$712.0K0.1%−9,253−18.2%ReducedHolders
Q2 202250,826$742.0K0.1%+40,282+382.0%AddedHolders
Q1 202210,544$177.0K<0.1%+10,544NewHolders
Q4 20210$00.0%−22,198−100.0%Sold outHolders
Q3 202122,198$478.0K<0.1%−11,553−34.2%ReducedHolders
Q2 202133,751$978.0K0.1%+33,751NewHolders